07:00 , Jun 1, 2015 |  BioCentury  |  Regulation

Formalizing function

FDA agreed with patients at a workshop on functional GI disorders that patient-reported outcomes measures should tease out the relationship between symptom relief and corresponding quality of life. But doing so presents a catch-22 for...